Concepedia

Publication | Closed Access

GS-12-Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial

31

Citations

0

References

2019

Year

No additional data available for this publication yet. Check back later!